PROCEPT BioRobotics Corporation Increase (Decrease) in Accounts Payable
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Accounts Payable of -$1.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$2.85M.
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.54M, a 59.08% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $5.93M.
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$789.00K, a 115.19% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for fiscal 2025 was $6.65M.
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for fiscal 2024 was -$2.15M, a 137.17% decline from fiscal 2023.
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for fiscal 2023 was $5.79M, a 46.22% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in accounts payable for fiscal 2022 was $3.96M, a 387.56% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.32M 10-Q · filed 2026-08-05 | $4.62M derived: sum of 3 quarters · filed 2026-08-05 | $3.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.54M 10-Q · filed 2026-04-30 | $7.47M derived: sum of 2 quarters · filed 2026-04-30 | $6.68M derived: sum of 3 quarters · filed 2026-04-30 | $4.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.14M derived: sum of 2 quarters · filed 2026-02-26 | $2.89M derived: sum of 3 quarters · filed 2026-08-05 | $6.65M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$789.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.04M derived: sum of 2 quarters · filed 2026-08-05 | $715.00K 10-Q · filed 2025-11-05 | -$4.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.50M 10-Q · filed 2026-08-05 | -$3.88M derived: sum of 3 quarters · filed 2026-08-05 | $1.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $3.75M 10-Q · filed 2026-04-30 | -$1.63M derived: sum of 2 quarters · filed 2026-04-30 | $3.57M derived: sum of 3 quarters · filed 2026-04-30 | $3.91M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$185.00K derived: sum of 2 quarters · filed 2026-02-26 | $159.00K derived: sum of 3 quarters · filed 2026-02-26 | -$2.15M 10-K · filed 2026-02-26 |
| 2024-09-30 | $5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.54M derived: sum of 2 quarters · filed 2025-11-05 | $3.23M 10-Q · filed 2025-11-05 | $9.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $344.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.97M 10-Q · filed 2025-08-07 | $3.91M derived: sum of 3 quarters · filed 2026-02-26 | $1.59M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$2.31M 10-Q · filed 2025-05-02 | $3.56M derived: sum of 2 quarters · filed 2026-02-26 | $1.24M derived: sum of 3 quarters · filed 2026-02-26 | $1.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.56M derived: sum of 2 quarters · filed 2026-02-26 | $3.56M derived: sum of 3 quarters · filed 2026-02-26 | $5.79M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | -$2.31M derived: sum of 2 quarters · filed 2024-10-28 | -$87.00K 10-Q · filed 2024-10-28 | -$371.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $2.23M 10-Q · filed 2024-08-02 | $1.95M derived: sum of 3 quarters · filed 2025-02-27 | $5.25M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.23M 10-Q · filed 2024-05-02 | $1.94M derived: sum of 2 quarters · filed 2025-02-27 | $5.24M derived: sum of 3 quarters · filed 2025-02-27 | $5.74M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.01M derived: sum of 2 quarters · filed 2025-02-27 | $3.51M derived: sum of 3 quarters · filed 2025-02-27 | $3.96M 10-K · filed 2025-02-27 |
| 2022-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.79M derived: sum of 2 quarters · filed 2023-11-02 | $4.24M 10-Q · filed 2023-11-02 | $2.69M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $499.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $947.00K 10-Q · filed 2023-07-28 | -$603.00K derived: sum of 3 quarters · filed 2024-02-28 | -$361.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $448.00K 10-Q · filed 2023-05-04 | -$1.10M derived: sum of 2 quarters · filed 2024-02-28 | -$860.00K derived: sum of 3 quarters · filed 2024-02-28 | $559.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$1.31M derived: sum of 2 quarters · filed 2024-02-28 | $111.00K derived: sum of 3 quarters · filed 2024-02-28 | $812.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.66M derived: sum of 2 quarters · filed 2022-11-04 | $2.36M 10-Q · filed 2022-11-04 | $2.42M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.12M 10-Q · filed 2022-08-05 | $2.18M derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $701.00K 10-Q · filed 2022-05-06 | $758.00K derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$205.00K 10-K · filed 2022-03-22 | ||
| 2020-09-30 | -$262.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |